Adage Capital Partners’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-925,000
| Closed | -$4.6M | – | 1149 |
|
|
2021
Q1 | $4.6M | Sell |
925,000
-750,000
| -45% | -$3.73M | 0.01% | 808 |
|
|
2020
Q4 | $7.22M | Hold |
1,675,000
| – | – | 0.02% | 647 |
|
|
2020
Q3 | $7.19M | Hold |
1,675,000
| – | – | 0.02% | 576 |
|
|
2020
Q2 | $7.52M | Sell |
1,675,000
-25,000
| -1% | -$112K | 0.02% | 562 |
|
|
2020
Q1 | $6.8M | Buy |
1,700,000
+50,000
| +3% | +$200K | 0.02% | 533 |
|
|
2019
Q4 | $14M | Hold |
1,650,000
| – | – | 0.03% | 475 |
|
|
2019
Q3 | $11.3M | Hold |
1,650,000
| – | – | 0.03% | 498 |
|
|
2019
Q2 | $13.7M | Hold |
1,650,000
| – | – | 0.03% | 448 |
|
|
2019
Q1 | $15.1M | Buy |
1,650,000
+615,000
| +59% | +$5.64M | 0.04% | 449 |
|
|
2018
Q4 | $11.3M | Buy |
1,035,000
+85,000
| +9% | +$931K | 0.03% | 484 |
|
|
2018
Q3 | $13.3M | Sell |
950,000
-25,000
| -3% | -$349K | 0.03% | 506 |
|
|
2018
Q2 | $10.4M | Buy |
+975,000
| New | +$10.4M | 0.02% | 556 |
|
|
2014
Q3 | – | Sell |
-1,075,825
| Closed | -$20.1M | – | 757 |
|
|
2014
Q2 | $20.1M | Buy |
1,075,825
+29,453
| +3% | +$549K | 0.05% | 396 |
|
|
2014
Q1 | $19.4M | Sell |
1,046,372
-275,000
| -21% | -$5.1M | 0.05% | 389 |
|
|
2013
Q4 | $14.8M | Buy |
+1,321,372
| New | +$14.8M | 0.04% | 454 |
|